Učitavanje...
Alzheimer's disease drug development pipeline: 2018
INTRODUCTION: Treatments for Alzheimer's disease (AD) are needed due to the growing number of individuals with preclinical, prodromal, and dementia forms of AD. Drug development for AD therapies can be examined by inspecting the drug development pipeline as represented on clinicaltrials.gov. ME...
Spremljeno u:
| Izdano u: | Alzheimers Dement (N Y) |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6021548/ https://ncbi.nlm.nih.gov/pubmed/29955663 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2018.03.009 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|